Friedman David Matthew — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Friedman David Matthew has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

David Matthew Friedman is identified in SEC filings as a Director of Veradermics, Inc. as of February 6, 2026. Beyond this board role, no additional publicly available biographical details are provided in the SEC documents reviewed. The record indicates he serves on Veradermics' board, but his broader professional background and prior affiliations are not disclosed in the provided SEC context.

Board memberships

• Veradermics, Inc

Awards & honors

• Directorship at Veradermics, Inc. as of 2026-02-06

Companies — Last 90 Days

• Benitec Biopharma Inc. (BNTC) — 1 filings, last 2026-05-29

Frequently Asked Questions

Who is Friedman David Matthew?

David Matthew Friedman is identified in SEC filings as a Director of Veradermics, Inc. as of February 6, 2026. Beyond this board role, no additional publicly available biographical details are provided in the SEC documents reviewed. The record indicates he serves on Veradermics' board, but his broader professional background and prior affiliations are not disclosed in the provi…

How many SEC Form 4 filings has Friedman David Matthew submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Friedman David Matthew's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week